arrow
F

Françesc Solé

Josep Carreras Leukaemia Research Institute
H指数:60
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Csnk1a1 E98 mutations rewire signaling and metabolism in del(5q) myelodysplastic neoplasms

Csnk1a1 E98突变重编程del(5q)骨髓增生异常性肿瘤的信号传导和代谢

Leukemia
IF13.4
2026-09-030
OA
Hair bulb and oral mucosa DNA for prompt germline testing in hematologic neoplasms

毛囊和口腔黏膜DNA用于血液肿瘤的快速胚系检测

2026-08-110
OA
Different SF3B1 Mutation Hotspots Show Hematopoietic Lineage-Specific VAF Patterns and Correlate with Distinct Genetic and Prognostic Profiles in Patients with Myeloid Neoplasms

不同SF3B1突变热点显示造血谱系特异的VAF模式,并与髓系肿瘤患者的独特遗传和预后特征相关

Cancers
IF4.4
2026-04-210
OAAI
Aligning Clinical Trial Reporting: A systematic analysis and position statement by the International Consortium for MDS

协调临床试验报告:国际骨髓增生异常综合征联盟的系统分析及立场声明

Blood
IF23.1
2026-01-010
PRE
The multiomics blueprint of the individual with the most extreme lifespan

具有最极端寿命个体的多组学蓝图

2025-09-240
OAAI
A Murine Model of Glioblastoma Initiating Cells and Human Brain Organoid Xenograft for Photodynamic Therapy Testing

一种胶质母细胞瘤起始细胞的啮齿动物模型及用于光动力疗法测试的人脑类器官异种移植

2025-09-210
OAAI
ACQUISITION OF MOLECULAR ALTERATIONS IN UNTREATED-LOW RISK MYELODYSPLASTIC SYNDROMES IS ASSOCIATED WITH POOR PROGNOSIS

未治疗低风险骨髓增生异常综合征中分子改变的发生与不良预后相关

2025-09-010
PRE
A COMPARISON OF PROGNOSTIC VARIABLES AND CYTOGENETIC ABERRATIONS IN 1590 PATIENTS WITH THERAPY-RELATED AND 4738 WITH PRIMARY MDS INCLUDING THE INFLUENCE OF TREATMENT IN MDS-PHASE

比较治疗相关和原发性MDS的1590例与4738例患者预后变量和细胞遗传学异常的比较,包括MDS阶段治疗的影响

2025-09-010
PRE
APPLICATION OF OPTICAL GENOME MAPPING IN MYELODYSPLASTIC SYNDROMES WITH NORMAL KARYOTYPE

光学基因组图谱在正常核型骨髓增生异常综合征中的应用

2025-09-010
PRE
APPLICATION OF OPTICAL GENOME MAPPING (OGM) IN ASSESSING THE GENOMIC COMPLEXITY IN PATIENTS WITH THERAPY-RELATED MYELOID NEOPLASMS AND MYELODYSPLASTIC SYNDROMES YOUNGER THAN 50 YEARS OLD

光学基因组图谱(OGM)在评估50岁以下接受治疗相关髓系肿瘤和骨髓增生异常综合征患者基因组复杂性中的应用

2025-09-010
PRE
Optical Genome Mapping (OGM): Validation and Clinical Utility in the Cytogenetic Diagnosis of Multiple Myeloma

光学基因组图谱(OGM):在多发性骨髓瘤细胞遗传学诊断中的验证和临床应用

2025-09-010
PRE
Integration of Optical Genome Mapping in the Cytogenomic and Molecular Work-Up of Hematological Malignancies: Expert Recommendations From the International Consortium for Optical Genome Mapping

在血液系统恶性肿瘤的细胞基因组学和分子研究中整合光学基因组图谱: 国际光学基因组图谱协会的专家建议

2025-04-300
PRE
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo

分泌抗BCMA T细胞衔接剂的工程化T细胞控制多发性骨髓瘤并促进体内免疫记忆

2024-02-145
PRE
A framework for the clinical implementation of optical genome mapping in hematologic malignancies

在血液系统恶性肿瘤中进行光学基因组定位的临床实施框架

2024-01-025
OAAI